Trial Profile
Phase 1, Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Mar 2017
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Cocaine-related disorders; Eating disorders; Opioid-related disorders; Substance-related disorders
- Focus Pharmacokinetics
- 01 Oct 2016 New trial record
- 20 Sep 2016 Results published in the Journal of Clinical Pharmacology, as per Adapt Pharma media release.